Online citations, reference lists, and bibliographies.
← Back to Search

Inclusion Complex Of Novel Curcumin Analogue CDF And β-Cyclodextrin (1:2) And Its Enhanced In Vivo Anticancer Activity Against Pancreatic Cancer

P. Dandawate, A. Vyas, A. Ahmad, S. Banerjee, J. Deshpande, K. Swamy, Abeda Jamadar, Anne Catherine Dumhe-Klaire, S. Padhye, F. Sarkar
Published 2012 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
PurposeSeveral formulations have been proposed to improve the systemic delivery of novel cancer therapeutic compounds, including cyclodextrin derivatives. We aimed to synthesize and characterize of CDF-β-cyclodextrin inclusion complex (1:2) (CDFCD).MethodsThe compound was characterized by Fourier transform infrared, differential scanning calorimetry, powder X-ray diffraction studies, H1 & C13 NMR studies and scanning electron microscopic analysis. Its activity was tested against multiple cancer cell lines, and in vivo bioavailability was checked.ResultsCDF-β-cyclodextrin was found to lower IC50 value by half when tested against multiple cancer cell lines. It preferentially accumulated in the pancreas, where levels of CDF-β-cyclodextrin in mice were 10 times higher than in serum, following intravenous administration of an aqueous CDF-β-cyclodextrin preparation.ConclusionsNovel curcumin analog CDF preferentially accumulates in the pancreas, leading to its potent anticancer activity against pancreatic cancer cells. Synthesis of such CDF-β-cyclodextrin self-assembly is an effective strategy to enhance its bioavailability and tissue distribution, warranting further evaluation for CDF delivery in clinical settings for treatment of human malignancies.
This paper references
10.1158/1940-6207.CAPR-11-0077
Inactivation of AR/TMPRSS2-ERG/Wnt Signaling Networks Attenuates the Aggressive Behavior of Prostate Cancer Cells
Y. Li (2011)
10.3322/caac.20107
Global cancer statistics
A. Jemal (2011)
10.1021/ci050075s
Impact of Conformational Flexibility on Three-Dimensional Similarity Searching Using Correlation Vectors
S. Renner (2006)
10.1021/jo801436h
A comparative study on the binding behaviors of beta-cyclodextrin and its two derivatives to four fanlike organic guests.
L. Song (2008)
10.1166/JBN.2009.022
Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization.
M. J. Santander-Ortega (2009)
In vitro release of curcumin from vehicles containing alginate and cyclodextrin. Studies of curcumin and curcuminoides. XXXIII.
A. Hegge (2008)
10.1371/journal.pone.0017850
Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
B. Bao (2011)
10.1016/J.SAA.2005.09.045
Determinations of the inclusion complex between gossypol and β-cyclodextrin
Y. Shen (2006)
Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems.
M. Uner (2006)
10.1158/0008-5472.CAN-09-4598
Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.
S. Ali (2010)
10.1021/jp1096025
Cooperative binding and stabilization of the medicinal pigment curcumin by diamide linked γ-cyclodextrin dimers: a spectroscopic characterization.
T. Harada (2011)
10.1007/s11095-009-9900-8
New Difluoro Knoevenagel Condensates of Curcumin, Their Schiff Bases and Copper Complexes as Proteasome Inhibitors and Apoptosis Inducers in Cancer Cells
S. Padhye (2009)
10.1016/S0009-2614(02)00410-4
Computer-aided molecular modeling techniques for predicting the stability of drug–cyclodextrin inclusion complexes in aqueous solutions
M. Faucci (2002)
10.1021/jf104223k
Interaction of curcumin and bixin with β-cyclodextrin: complexation methods, stability, and applications in food.
Vanessa Aparecida Marcolino (2011)
10.1196/annals.1352.010
Curcumin: Getting Back to the Roots
S. Shishodia (2005)
Computer-aidedmolecularmodeling techniques for predicting the stability of drug-cyclodextrin inclusion complexes in aqueous solutions
FaucciMT (2002)
10.1021/BM060570C
PEGylated Nanoparticles based on a polyaspartamide. preparation, physico-chemical characterization, and intracellular uptake.
E. Craparo (2006)
10.1021/MP700113R
Bioavailability of curcumin: problems and promises.
P. Anand (2007)
Poly(beta-cyclodextrin)/ curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells
Mm Yallapu (2010)
10.1016/j.bcp.2010.06.022
Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake.
V. Yadav (2010)
Preparation and Stability investigation of the inclusion complex of sulforaphane with hydroxypropyl-beta-cyclodextrin
H Wu (2010)
10.1002/mabi.201000084
Poly(β-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells.
Murali M Yallapu (2010)
10.1021/ED077P359
Isolation of Curcumin from Turmeric
A. Anderson (2000)
10.1016/S0013-4686(02)00252-9
Inclusion complexation of (11-ferrocenylundecyl)trimethylammonium bromide by β-cyclodextrin and its effects on electrochemical behavior of the surfactant
Teruhisa Komura (2002)
10.1016/S0066-4103(08)60265-3
NMR Studies of the Structure and Properties of Cyclodextrins and Their Inclusion Complexes
Y. Inoue (1993)
10.1016/j.colsurfb.2010.03.039
beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells.
Murali M Yallapu (2010)
Physico-chemical characterization of polysaccharidecoated nanoparticles
C Lemarchand (2005)
10.1016/J.JORGANCHEM.2011.01.007
Correlation of the formation constant of ferrocene–cyclodextrin complexes with dielectric properties of the aqueous DMSO solution
V. Kolivoška (2011)
10.1016/j.saa.2011.02.030
Study of inclusion complex of β-cyclodextrin and diphenylamine: photophysical and electrochemical behaviors.
K. Srinivasan (2011)
Spectrochim Acta A Mol Biomol Spectrosc
(2006)
10.1016/J.CARBPOL.2010.05.020
Preparation and stability investigation of the inclusion complex of sulforaphane with hydroxypropyl-β-cyclodextrin
Huahua Wu (2010)
10.1208/s12248-009-9128-x
Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?
J. Ravindran (2009)
10.1208/s12249-009-9264-8
Effect of Cyclodextrin Complexation of Curcumin on its Solubility and Antiangiogenic and Anti-inflammatory Activity in Rat Colitis Model
Vivek R. Yadav (2009)
10.1166/JBN.2011.1296
Curcumin-loaded lipid and polymeric nanocapsules stabilized by nonionic surfactants: an in vitro and In vivo antitumor activity on B16-F10 melanoma and macrophage uptake comparative study.
L. Mazzarino (2011)
10.1007/s11095-009-9955-6
Fluorocurcumins as Cyclooxygenase-2 Inhibitor: Molecular Docking, Pharmacokinetics and Tissue Distribution in Mice
S. Padhye (2009)
10.1166/JNN.2011.3093
Preparation and characterization of lyophilised egg PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines.
Maria Pandelidou (2011)
Phase solubility techniques
T. Higuchi (1965)
NMR studies of the inclusion complex between beta-cyclodextrin and paroxetine.
A. Bernini (2004)
10.1016/j.nano.2011.07.011
Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma.
S. Dhule (2012)
PLoS One
(2011)
10.2174/138920012798356952
Design of curcumin loaded cellulose nanoparticles for prostate cancer.
Murali M Yallapu (2012)
10.1021/mp700144t
Supramolecular nanoencapsulation as a tool: solubilization of the anticancer drug trans-dichloro(dipyridine)platinum(II) by complexation with beta-cyclodextrin.
G. Horvath (2008)
Determinations of the inclusion complex between gossypol and beta-cyclodextrin.
Y. Shen (2006)
10.1007/s11095-010-0336-y
Difluorinated-Curcumin (CDF): A Novel Curcumin Analog is a Potent Inhibitor of Colon Cancer Stem-Like Cells
S. Kanwar (2010)
10.1158/0008-5472.CAN-11-2182
Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression.
B. Bao (2012)
10.1016/J.JCONREL.2005.07.014
Physico-chemical characterization of polysaccharide-coated nanoparticles.
C. Lemarchand (2005)
10.1016/J.EJPS.2004.04.007
NMR studies of the inclusion complex between β-cyclodextrin and paroxetine
A. Bernini (2004)
10.1016/j.carres.2010.08.018
Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation.
C. Garnero (2010)
Global cancer statistics. CA Cancer J Clin
A Jemal (2011)



This paper is referenced by
10.1145/3314367.3314381
β-Cyclodextrin Inclusion Complex with Dimethyl[4-hydroxypiperidin-4-yl]Phosphonates as Green Plant Growth Stimulators
A. Y. Malmakova (2019)
10.1208/s12249-013-0068-5
SN-38-Cyclodextrin Complexation and Its Influence on the Solubility, Stability, and In Vitro Anticancer Activity Against Ovarian Cancer
K. Vangara (2013)
Turmeric and Pancreatic Cancer- A Review
J. N. Jacob (2013)
10.3390/ijms19010107
The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review
Inamul Haque (2017)
10.3906/kim-1910-43
Selective modifications at the different positions of cyclodextrins: a review of strategies
J. Liu (2020)
10.3390/polym12071564
Effect of Hydrophilic Polymers on Complexation Efficiency of Cyclodextrins in Enhancing Solubility and Release of Diflunisal
Mehreen Bashir (2020)
Molecular docking and inhibition of matrix metalloproteinase-2 by novel difluorinatedbenzylidene curcumin analog.
A. Ahmad (2015)
10.1016/j.carbpol.2013.08.078
Cyclodextrins as encapsulation agents for plant bioactive compounds.
E. Pinho (2014)
10.1007/s12011-014-9886-x
Erratum to: Comparative In Vivo Evaluations of Curcumin and Its Analog Difluorinated Curcumin Against Cisplatin-Induced Nephrotoxicity
K. Şahin (2014)
10.1371/journal.pone.0142928
Mechanism of Action of Two Flavone Isomers Targeting Cancer Cells with Varying Cell Differentiation Status
Timothy M. LeJeune (2015)
10.1016/J.MOLSTRUC.2015.08.054
Inclusion complex of ellagic acid with β-cyclodextrin: Characterization and in vitro anti-inflammatory evaluation
V. D. Bulani (2016)
10.1016/j.carbpol.2019.115805
Cyclodextrin-based delivery systems for chemotherapeutic anticancer drugs: A review.
Bingren Tian (2020)
10.1016/j.carbpol.2018.09.080
Nintedanib-cyclodextrin complex to improve bio-activity and intestinal permeability.
B. Vaidya (2019)
10.3390/polym10020111
Enhanced Solubilization of Fluoranthene by Hydroxypropyl β-Cyclodextrin Oligomer for Bioremediation
Kyeong Hui Park (2018)
10.1021/acs.biomac.5b00941
Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem-Like Pancreatic Cancer Cells.
P. Kesharwani (2015)
10.1021/acsami.5b01786
Dual-responsive polymer coated superparamagnetic nanoparticle for targeted drug delivery and hyperthermia treatment.
S. Patra (2015)
10.1007/978-94-007-4819-4_17
Network Pharmacology: An Emerging Area in Anti-Cancer Drug Discovery
A. Azmi (2012)
10.1016/B978-0-12-804307-3.00008-9
Supramolecular strategy of the encapsulation of low-molecular-weight food ingredients
L. Y. Zakharova (2016)
10.1016/j.carbpol.2017.02.081
Preparation, characterization and in vitro biological evaluation of (1:2) phenoxodiol-β-cyclodextrin complex.
Eugene Yee (2017)
10.1007/s10853-017-1720-3
Designing and monitoring microstructural properties of oligosaccharide/co-solvent ternary complex particles to improve benznidazole dissolution
Polyanne N. de Melo (2017)
10.1080/03639045.2016.1236808
Pharmacodynamic and pharmacokinetic investigation of cyclodextrin-mediated asenapine maleate in situ nasal gel for improved bioavailability
J. A. Kulkarni (2017)
Curcumin: A Multi-dimensional Approach to Pancreatic Cancer Targeting Cell Death and Exosomes
C. Osterman (2015)
10.3389/fphar.2020.00487
Nanocurcumin: A Promising Candidate for Therapeutic Applications
A. Karthikeyan (2020)
10.1080/09168451.2016.1171696
Synthesis, characterization and fluorescent properties of water-soluble glycopolymer bearing curcumin pendant residues
Haisong Zhang (2016)
10.1021/am503655z
Acid-induced release of curcumin from calcium containing nanotheranostic excipient.
Aifei Wang (2014)
10.1016/j.semcancer.2016.09.001
Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.
P. Dandawate (2016)
10.4172/2157-7633.S7-005
Systems and Network Pharmacology Approaches to Cancer Stem Cells Research and Therapy.
Irfana Muqbil (2012)
10.1007/s10847-013-0293-2
Topical emulgel formulation containing inclusion complex of calcipotriol with cyclodextrin
Ulya Badilli (2013)
10.3390/pharmaceutics9040039
Nanotechnologies in Pancreatic Cancer Therapy
A. Manzur (2017)
10.1007/s10847-015-0498-7
Characterisation and anti-inflammatory evaluation of the inclusion complex of ellagic acid with hydroxypropyl-β-cyclodextrin
V. D. Bulani (2015)
10.1021/jp412041d
Cooperative Binding of Cyclodextrin Dimers to Isoflavone Analogues Elucidated by Free Energy Calculations
H. Zhang (2014)
10.2174/1381612811319110003
Recent progress in studying curcumin and its nano-preparations for cancer therapy.
J. Liu (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar